| 000 | 02017pam a2200361 a 4500 | ||
|---|---|---|---|
| 999 |
_c12903 _d12903 |
||
| 001 | 2543540 | ||
| 005 | 20210307144855.0 | ||
| 008 | 941024s1995 ctua 001 0 eng d | ||
| 010 | _a 94040831 | ||
| 020 | _a0838589464 | ||
| 040 |
_aEG-NcFUE _cEG-NcFUE _dEG-NcFUE _erda |
||
| 050 | 0 | 0 |
_aRM301.9 _b.T48 1995 |
| 060 | 1 | 0 | _aWB 330 T3985 1995 |
| 082 | 0 | 0 |
_a615.58 _220 _bT |
| 245 | 0 | 0 |
_aTherapeutic drug monitoring / _cedited by Gerald E. Schumacher. |
| 264 | 1 |
_aNorwalk, Conn. : _bAppleton & Lange, _c[1995] |
|
| 264 | 4 | _a©1995. | |
| 300 |
_axii, 684 pages : _billustrations ; _c25 cm. |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarrier _avolume |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aIntroduction to Therapeutic Drug Monitoring. Pharmackinetic Concepts in Therapeutic Drug Monitoring. The Total Testing Process Applied to Therapeutic Drug Monitoring. Developing and operating a Therapeutic Drug Monitoring Service. Monitoring Drug Therapy. Population Approaches to Pharmacokinetics and Risk Management. Decision Analysis Applied to Therapeutic Drug Monitoring. Outcomes Assessment of Therapeutic Drug Monitoring. Aminoglycosides. Antiarrhythmics. Antiepileptics. Chloramphenicol. Cyclic Antidepressants. Cyclosporine. Digoxin. Lithium. Methotrexate. Theophylline. Vancomycin. | |
| 520 | _aExamines the use of drug serum concentrations, pharmacokinetics, and pharmacodynamics to individualize and optimize patient responses to drug therapy. This book explains the merits, limitations, and applications of using serum drug concentrations in quantitative decision making. | ||
| 650 | 0 | _aDrug monitoring. | |
| 650 | 1 | 2 | _aDrug Monitoring. |
| 650 | 2 | 2 | _aDrugs. |
| 700 | 1 |
_aSchumacher, Gerald E. _eeditor |
|
| 906 |
_a7 _bcbc _corignew _d1 _eocip _f19 _gy-gencatlg |
||
| 942 |
_2ddc _cBK |
||